Dr. Milad Alucozai is an Afghan-American neuroscientist, entrepreneur, and life sciences investor. With a strong commitment to commercializing transformative technologies and fostering startup ecosystems worldwide, he is a thought leader and mentor through organizations like Creative Destruction Lab and the Wyss Institute at Harvard University.
Milad started his career in translational neuroscience and multiphysicslaboratories before transitioning into founding roles at biotech startups and global consulting companies. He supports founders with strategy, scaling, business development, securing growth capital, and leadership training.
Milad serves as a Fellow in Healthcare Engineering at the RegenstriefCenter. In 2020, he served as an External Advisor to AstraZeneca. He was recognized as a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honours Program. As a George J. Mitchell Scholar, he completed his Master’s in Immunology and earned his doctorate from the Richard M. Fairbanks School of Public Health.